1 week Ago
Mind Medicine (MindMed) Inc. ( NASDAQ: MNMD ) Q1 2024 Earnings Conference Call May 8, 2024 4:30 PM ET Company Participants Robert Barrow - Chief Executive Officer Daniel Karlin - Chief Medical Officer Francois Lilienthal - Chief Commercial Officer Conference Call Participants Rudy Li - Leerink Partners LLC Brian Abrahams - RBC Capital Markets Elaine Kim - Cantor Fitzgerald Daniel Hultberg - Oppenheimer Sumant Kulkarni - Canaccord Genuity, LLC Elemer Piros - Rodman & Renshaw Patrick Trucchio - H.C.
Wainwright & Co. Operator Good day, and thank you for standing by. Welcome to the MindMed Q1 2024 Earnings Conference Call.
At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your first speaker today, Rob Barrow, CEO of MindMed. Please go ahead. Robert Barrow Thank you, and good afternoon, everyone.
Welcome to our first quarter 2024 financial results and corporate update conference call. The press release reporting our financial results is available in the Investors and Media section of our website, and our quarterly report on Form 10-Q for the quarter ended March 31, 2024, is being filed today with the Securities and Exchange Commission. During today's call, we will be making certain forward-looking statements, including, without limitation, statements about the pote.
